You are here: Home » News-CM » Companies » Results
Business Standard

Claris Lifesciences reports standalone net loss of Rs 5.74 crore in the March 2017 quarter

Capital Market 

Sales decline 65.40% to Rs 3.09 crore

Net loss of Claris Lifesciences reported to Rs 5.74 crore in the quarter ended March 2017 as against net profit of Rs 0.44 crore during the previous quarter ended March 2016. Sales declined 65.40% to Rs 3.09 crore in the quarter ended March 2017 as against Rs 8.93 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 11.56 crore in the year ended March 2017 as against net loss of Rs 20.26 crore during the previous year ended March 2016. Sales declined 82.70% to Rs 21.12 crore in the year ended March 2017 as against Rs 122.05 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales3.098.93 -65 21.12122.05 -83 OPM %-277.99-226.43 --279.55-64.21 - PBDT-8.45-4.39 -92 1.90-19.00 LP PBT-9.52-5.30 -80 -1.42-22.56 94 NP-5.740.44 PL 11.56-20.26 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Claris Lifesciences reports standalone net loss of Rs 5.74 crore in the March 2017 quarter

Sales decline 65.40% to Rs 3.09 crore

Sales decline 65.40% to Rs 3.09 crore

Net loss of Claris Lifesciences reported to Rs 5.74 crore in the quarter ended March 2017 as against net profit of Rs 0.44 crore during the previous quarter ended March 2016. Sales declined 65.40% to Rs 3.09 crore in the quarter ended March 2017 as against Rs 8.93 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 11.56 crore in the year ended March 2017 as against net loss of Rs 20.26 crore during the previous year ended March 2016. Sales declined 82.70% to Rs 21.12 crore in the year ended March 2017 as against Rs 122.05 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales3.098.93 -65 21.12122.05 -83 OPM %-277.99-226.43 --279.55-64.21 - PBDT-8.45-4.39 -92 1.90-19.00 LP PBT-9.52-5.30 -80 -1.42-22.56 94 NP-5.740.44 PL 11.56-20.26 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Claris Lifesciences reports standalone net loss of Rs 5.74 crore in the March 2017 quarter

Sales decline 65.40% to Rs 3.09 crore

Net loss of Claris Lifesciences reported to Rs 5.74 crore in the quarter ended March 2017 as against net profit of Rs 0.44 crore during the previous quarter ended March 2016. Sales declined 65.40% to Rs 3.09 crore in the quarter ended March 2017 as against Rs 8.93 crore during the previous quarter ended March 2016.

For the full year,net profit reported to Rs 11.56 crore in the year ended March 2017 as against net loss of Rs 20.26 crore during the previous year ended March 2016. Sales declined 82.70% to Rs 21.12 crore in the year ended March 2017 as against Rs 122.05 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales3.098.93 -65 21.12122.05 -83 OPM %-277.99-226.43 --279.55-64.21 - PBDT-8.45-4.39 -92 1.90-19.00 LP PBT-9.52-5.30 -80 -1.42-22.56 94 NP-5.740.44 PL 11.56-20.26 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22